|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||44.200 - 44.380|
|52 Week Range||33.380 - 44.730|
|PE Ratio (TTM)||29.09|
|Dividend & Yield||0.72 (1.61%)|
|1y Target Est||39.80|
L'Oreal (OREP.PA) said on Thursday it would appeal a 2.6 million euro ($3 million) fine imposed by Greece's competition authority, which ruled that the French cosmetics company and several of its rivals were fixing prices. The local beauty products business of France's Christian Dior - part of luxury goods group LVMH (LVMH.PA) - was also fined just under 1.8 million euros, while U.S.-based Estee Lauder (EL.N) got the biggest fine, at 5.4 million euros. Three Greek companies were included in the six.
L'Oreal (OREP.PA) said on Thursday it would appeal a 2.6 million euro (2.32 million pounds) fine imposed by Greece's competition authority, which ruled that the French cosmetics company and several of its rivals were fixing prices. The local beauty products business of France's Christian Dior - part of luxury goods group LVMH (LVMH.PA) - was also fined just under 1.8 million euros, while U.S.-based Estee Lauder (EL.N) got the biggest fine, at 5.4 million euros. Three Greek companies were included in the six.
French Prime Minister Edouard Philippe said any takeover of cosmetics maker L’Oreal SA would be watched carefully by the government though the company isn’t necessarily a strategic asset.
The death this week of L’Oreal SA’s founding family matriarch is putting the spotlight on a reclusive 64-year-old heiress who now finds herself as the richest woman in the world.
Liliane Bettencourt, the world's richest woman and heiress to the conglomerate giant L'Oreal SA (ADR) (OTC: LRLCY ), passed away Thursday at the age of 94. This raises the question of what will come next ...
The death of billionaire Liliane Bettencourt focused attention on Friday on how L'Oreal's founding family and major shareholder Nestle (NESN.S) would manage their stakes in the world's biggest cosmetics firm. Bettencourt, listed by Forbes as the world's richest woman and heiress to the company started by her father, died at the age of 94, relatives said late on Thursday. Bettencourt's family owns 33 percent of L'Oreal.
L’Oreal SA shares surged the most in seven years on speculation that the death of the founding family’s matriarch, Liliane Bettencourt, could clear up the cosmetics maker’s ownership through a takeover ...
Regularly named France's richest person and for years the wealthiest woman in the world thanks to her L'Oreal inheritance, Liliane Bettencourt lived her life surrounded by the scent of money, politics and more than a touch of scandal. For most of her nine decades she was better known for who she was than for what she did, even though her first job, at the age of 15, was as an apprentice in a L'Oreal factory, mixing cosmetics and labeling bottles of shampoo. The daughter of L'Oreal founder Eugene Schueller, to whom she was always close, in 1950, at the age of 28, she married Andre Bettencourt, a government minister of the 1960s and 70s under President Charles de Gaulle.
French businesswoman and billionaire Liliane Bettencourt, whose family founded L'Oreal and still owns the largest stake in the cosmetics giant, has died aged 94, her daughter said on Thursday. Bettencourt, listed by Forbes as the world's richest woman, was the heiress to the beauty and comestics company her father founded just over a century ago as a maker of hair dye. Bettencourt and her family owned 33 percent of the company.
The world's wealthiest woman, L'Oreal heiress Liliane Bettencourt, has died, according to a statement from her daughter on Thursday. She was 94 and was the thirteenth richest person in the world at the time of her death, with a net worth that Forbes estimates at $44.7 billion.
PARIS (AP) — Liliane Bettencourt, the L'Oreal cosmetics heiress and the world's richest woman, has died at her home in a chic Parisian suburb. She was 94.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to L’Oréal SA Here are 5 ETFs with the largest exposure to LRLCY-US. Comparing the performance and risk of L’Oréal SA with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was under pressure last week amid reports that mutual fund company Lord Abbett & Co. has filed a securities fraud lawsuit against Valeant, alleging that it bought VRX’s debt securities at artificially inflated price based on misleading information provided by Valeant. The lawsuit Lord Abbett filed in federal court in New Jersey — location of Valeant’s U.S. headquarter — seeks damages of $80 billion in investor losses and under the New Jersey’s racketeer influenced and corrupt organizations (RICO) laws. There have been tons of reason to be skeptical about Valeant Pharmaceuticals’ future and, in particular, the company’s ability to pay its massive debt pile of $28.5 billion, while it has just $1.5 billion in cash.
Categories: Yahoo FinanceGet free summary analysis L’Oréal SA reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of L’Oréal SA – Procter & Gamble Company, Revlon, Inc. Class A, Avon Products, Inc., Inter Parfums, Inc., Unilever PLC Sponsored ADR, Sally Beauty Holdings, Inc. and Sanofi Sponsored ADR ... Read more (Read more...)
There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock ahead of its second-quarter fiscal 2017 earnings results before Tuesday’s opening bell. The embattled drugmaker continues to make operational improvements, including divesting various non-core assets to lower debts. Since falling to a 52-week low of $8.31 on April 24, Valeant stock has skyrocketed as much as 118%, reaching $18.17 on July 25.
Ulta Beauty Inc (NASDAQ: ULTA )'s nearly 15 percent sell-off over the past month could be the beginning of the stock's longer-term trend, analysts at Oppenheimer said. The firm's Rupesh Parikh downgrades ...
Has embattled drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) finally bottomed? Can VRX stock ever be trusted again? The market seems willing to bet that Valeant — which in the first quarter posted its first profit in six quarters and then raised guidance for 2017 — can not only sustain its operations but thrive.
Rating Action: Moody's affirms Nestlé's Aa2 rating; stable outlook. Global Credit Research- 28 Jun 2017. Milan, June 28, 2017-- Moody's Investors Service has today affirmed the Aa2 issuer rating of the ...